Immunome, Inc. (IMNM) Revenue 2023–2025
Immunome, Inc. (IMNM) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$6.9MFY2025 · since FY2023: $14.0M → $6.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $6.9M | -23.2% |
| FY2024 | $9.0M | -35.5% |
| FY2023 | $14.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More IMNM financial trends
IMNM Net incomeIMNM Net marginIMNM Gross profitIMNM Gross marginIMNM Operating incomeIMNM Operating marginIMNM Operating cash flowIMNM Free cash flowIMNM Capital expendituresIMNM Return on equityIMNM Stock buybacksIMNM Dividends paidIMNM Total assetsIMNM Total liabilitiesIMNM Shareholders’ equityIMNM overview →